Beijing Kowloon Pharmaceutical Factory
FDA import alert and refusal historyBeijing, ChinaFEI 3003880203
As of October 26, 2026, Beijing Kowloon Pharmaceutical Factory (Beijing, China) is on the red list of FDA Import Alert 54-16 (Foods/supplements with active pharmaceutical ingredient) for 4everon sexual stimulant tablets (declared as l-arginine dietary supplement), published by FDA on June 29, 2015, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 54-16 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Beijing Kowloon Pharmaceutical Factory
1 record, newest first. Each line links to the FDA page it came from.
2015
- Import alert listingListed on Import Alert 54-16red list4Everon Sexual Stimulant Tablets (declared as L-Arginine dietary supplement)Source
Questions about Beijing Kowloon Pharmaceutical Factory
- Is Beijing Kowloon Pharmaceutical Factory on an FDA import alert?
- Yes. As of October 26, 2026, Beijing Kowloon Pharmaceutical Factory is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for 4everon sexual stimulant tablets (declared as l-arginine dietary supplement); FDA published the listing on June 29, 2015.
- Has FDA refused shipments from Beijing Kowloon Pharmaceutical Factory?
- No FDA import refusals for Beijing Kowloon Pharmaceutical Factory appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Beijing Kowloon Pharmaceutical Factory's FEI number?
- Beijing Kowloon Pharmaceutical Factory's FDA Establishment Identifier (FEI) is 3003880203.
- Can shipments from Beijing Kowloon Pharmaceutical Factory still enter the U.S.?
- Shipments of 4everon sexual stimulant tablets (declared as l-arginine dietary supplement) from Beijing Kowloon Pharmaceutical Factory can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Beijing Kowloon Pharmaceutical Factory?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.